Viyash ScientificNSE:VIYASH -0.72%72 Net Margin % is 5.66% as of Mar. 2026, which is 48% above its 10-year median of 3.83. GuruFocus rates NSE:VIYASH with a GF Score™ of 72/100 and a GF Value™ of ₹171.37 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Viyash Scientific ranks worse than 53.14% on this metric.
The historical rank and industry rank for Viyash Scientific's Net Margin % or its related term are showing as below:
NSE:VIYASH'
s Net Margin % Range Over the Past 10 Years
Min: -8.54 Med: 3.83 Max: 50.07
Current: 4.52
NSE:VIYASH's Net Margin % is ranked worse than 53.14% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs NSE:VIYASH: 4.52
Viyash Scientific (NSE:VIYASH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Viyash Scientific Net Margin % Related Terms
Viyash Scientific Net Margin % Historical Data
* Premium members only.
The historical data trend for Viyash Scientific's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Viyash Scientific's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viyash Scientific Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viyash Scientific's Net Margin % distribution charts can be found below:
* The bar in red indicates where Viyash Scientific's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viyash Scientific (NSE:VIYASH) has a Net Margin % of 5.66% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Viyash Scientific and its competitors. This is 48% above median its historical median of 3.83. According to the industry distribution chart, Viyash Scientific ranks #508 out of 956 companies in the Drug Manufacturers industry, placing it in the top 53.1%.
Is Viyash Scientific's Net Margin % too high?
Viyash Scientific's current Net Margin % of 5.66% is 48% above median its 10-year median of 3.83. The Drug Manufacturers industry median Net Margin % is 5.56. Viyash Scientific's value of 5.66% is 1.8% above this industry median. Based on the distribution chart, Viyash Scientific ranks #508 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Viyash Scientific has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viyash Scientific's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Viyash Scientific ranks #508 out of 956 companies for Net Margin %. This places Viyash Scientific in the lower half of its industry. The industry median Net Margin % is 5.56. Viyash Scientific's value of 5.66% is 1.8% above this benchmark. While the company's 10-year median is 3.83 vs. the industry median of 5.56, Viyash Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viyash Scientific's current Net Margin % of 5.66% is 1.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Viyash Scientific and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viyash Scientific's current Net Margin % is 5.66%, which is 48% above median its own 10-year median of 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viyash Scientific stock overvalued right now?
Based on GuruFocus' analysis, Viyash Scientific (NSE:VIYASH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹171.37, compared to a current price of ₹269.30 — trading 57.1% above its estimated fair value. The current Net Margin % is 5.66%, which is 48% above median its 10-year median of 3.83 and 1.8% above the Drug Manufacturers industry median of 5.56. Viyash Scientific's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Viyash Scientific (NSE:VIYASH), the current Net Margin % is 5.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viyash Scientific (NSE:VIYASH) Overvalued in 2026?
Based on GuruFocus' analysis, Viyash Scientific stock appears to be overvalued.
The current stock price of ₹269.30 is trading 57.1% above its estimated GF Value™ of ₹171.37.
GuruFocus considers Viyash Scientific to be Significantly Overvalued.
Key valuation signals for NSE:VIYASH:
Net Margin %: 5.66% (48% above median its 10-year median of 3.83)
GF Value™: ₹171.37 vs. price of ₹269.30 (57.1% above fair value)
Industry Position: 1.8% above the Drug Manufacturers median (#508 of 956)
No single metric tells the full story. See the NSE:VIYASH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
72GF Score
Get the complete analysis for NSE:VIYASH
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIYASH has been successfully added to your 
